AbbVie rival Gilead makes exclusive deal with CVS for Hep C drugs

(Source: Crain’s Chicago Business) Express Scripts has about 30 percent to 33 percent of the U.S. pharmacy benefits management market, and CVS 27 percent to 30 percent, according to Robyn …